Literature DB >> 21490095

Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Isabelle Dietrich1, Elizabeth L McMonagle, Sarah J Petit, Swetha Vijayakrishnan, Nicola Logan, Chi N Chan, Greg J Towers, Margaret J Hosie, Brian J Willett.   

Abstract

Domestic cats endure infections by all three subfamilies of the retroviridae: lentiviruses (feline immunodeficiency virus [FIV]), gammaretroviruses (feline leukemia virus [FeLV]), and spumaretroviruses (feline foamy virus [FFV]). Thus, cats present an insight into the evolution of the host-retrovirus relationship and the development of intrinsic/innate immune mechanisms. Tetherin (BST-2) is an interferon-inducible transmembrane protein that inhibits the release of enveloped viruses from infected cells. Here, we characterize the feline homologue of tetherin and assess its effects on the replication of FIV. Tetherin was expressed in many feline cell lines, and expression was induced by interferons, including alpha interferon (IFN-α), IFN-ω, and IFN-γ. Like human tetherin, feline tetherin displayed potent inhibition of FIV and HIV-1 particle release; however, this activity resisted antagonism by either HIV-1 Vpu or the FIV Env and "OrfA" proteins. Further, as overexpression of complete FIV genomes in trans could not overcome feline tetherin, these data suggest that FIV lacks a functional tetherin antagonist. However, when expressed stably in feline cell lines, tetherin did not abrogate the replication of FIV; indeed, syncytium formation was significantly enhanced in tetherin-expressing cells infected with cell culture-adapted (CD134-independent) strains of FIV (FIV Fca-F14 and FIV Pco-CoLV). Thus, while tetherin may prevent the release of nascent viral particles, cell-to-cell spread remains efficient in the presence of abundant viral receptors and tetherin upregulation may enhance syncytium formation. Accordingly, tetherin expression in vivo may promote the selective expansion of viral variants capable of more efficient cell-to-cell spread.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490095      PMCID: PMC3126296          DOI: 10.1128/JVI.00071-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  BST-2/tetherin: a new component of the innate immune response to enveloped viruses.

Authors:  David T Evans; Ruth Serra-Moreno; Rajendra K Singh; John C Guatelli
Journal:  Trends Microbiol       Date:  2010-08-03       Impact factor: 17.079

Review 5.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

Review 7.  FIV: from lentivirus to lentivector.

Authors:  Dyana T Saenz; Eric M Poeschla
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

8.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

9.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

10.  A tail of Tetherin: how pandemic HIV-1 conquered the world.

Authors:  Ravindra K Gupta; Greg J Towers
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

View more
  39 in total

1.  Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons.

Authors:  Sreeja Sarojini; Thana Theofanis; Carol Shoshkes Reiss
Journal:  DNA Cell Biol       Date:  2011-09-15       Impact factor: 3.311

2.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

3.  Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.

Authors:  Michele Celestino; Arianna Calistri; Claudia Del Vecchio; Cristiano Salata; Flavia Chiuppesi; Mauro Pistello; Alessandra Borsetti; Giorgio Palù; Cristina Parolin
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

4.  Innate sensing of foamy viruses by human hematopoietic cells.

Authors:  Réjane Rua; Alice Lepelley; Antoine Gessain; Olivier Schwartz
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

5.  Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.

Authors:  Jumpei Ito; Shinya Watanabe; Takahiro Hiratsuka; Kyohei Kuse; Yuka Odahara; Haruyo Ochi; Maki Kawamura; Kazuo Nishigaki
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.

Authors:  Maria J Polyak; Pornpun Vivithanaporn; Ferdinand G Maingat; John G Walsh; William Branton; Eric A Cohen; Rick Meeker; Christopher Power
Journal:  FASEB J       Date:  2013-04-22       Impact factor: 5.191

7.  The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.

Authors:  Cécile Lemaître; Francis Harper; Gérard Pierron; Thierry Heidmann; Marie Dewannieux
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

8.  Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.

Authors:  Xin Yin; Zhe Hu; Qinyong Gu; Xingliang Wu; Yong-Hui Zheng; Ping Wei; Xiaojun Wang
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 9.  How SAMHD1 changes our view of viral restriction.

Authors:  Nadine Laguette; Monsef Benkirane
Journal:  Trends Immunol       Date:  2011-12-15       Impact factor: 16.687

10.  Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Authors:  Sam X Li; Bradley S Barrett; Karl J Heilman; Ronald J Messer; Rachel A Liberatore; Paul D Bieniasz; George Kassiotis; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2014-05-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.